Page last updated: 2024-09-03

sch 23982 and 1,3-dipropyl-8-cyclopentylxanthine

sch 23982 has been researched along with 1,3-dipropyl-8-cyclopentylxanthine in 1 studies

Compound Research Comparison

Studies
(sch 23982)
Trials
(sch 23982)
Recent Studies (post-2010)
(sch 23982)
Studies
(1,3-dipropyl-8-cyclopentylxanthine)
Trials
(1,3-dipropyl-8-cyclopentylxanthine)
Recent Studies (post-2010) (1,3-dipropyl-8-cyclopentylxanthine)
87001,3011165

Protein Interaction Comparison

ProteinTaxonomysch 23982 (IC50)1,3-dipropyl-8-cyclopentylxanthine (IC50)
Adenosine receptor A1Rattus norvegicus (Norway rat)0.0051
Adenosine receptor A3Rattus norvegicus (Norway rat)0.0038
Adenosine receptor A2aHomo sapiens (human)0.2033
Adenosine receptor A2bHomo sapiens (human)0.0234
Adenosine receptor A1Homo sapiens (human)0.0083

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ferré, S; Fredholm, BB; Fuxe, K; Lillrank, SM; Lipska, BK; Weinberger, DR1

Other Studies

1 other study(ies) available for sch 23982 and 1,3-dipropyl-8-cyclopentylxanthine

ArticleYear
Adenosine and dopamine receptor antagonist binding in the rat ventral and dorsal striatum: lack of changes after a neonatal bilateral lesion of the ventral hippocampus.
    Neurochemistry international, 1999, Volume: 34, Issue:3

    Topics: Animals; Animals, Newborn; Antipsychotic Agents; Benzazepines; Corpus Striatum; Disease Models, Animal; Dopamine Antagonists; Female; Hippocampus; Male; Pregnancy; Purinergic P1 Receptor Antagonists; Pyrimidines; Raclopride; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Salicylamides; Schizophrenia; Triazoles; Xanthines

1999